Rocket


News + Filings
Transactions



Alles Mark J

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/01/2023Syros Pharmaceuticals, Inc.SYRSGrantRestricted Stock Units4k$0.00$0 06/01/2023
06/01/2023Syros Pharmaceuticals, Inc.SYRSGrantStock Option (right to buy)6k$3.70$22.2k 06/01/2023
05/23/2023BIOMARIN PHARMACEUTICAL INCBMRNGrantCommon Stock4.2k$0.00$0 05/23/2023
09/16/2022Syros Pharmaceuticals, Inc.SYRSGrantStock Option (right to buy)12k$7.35$88.2k 09/16/2022
09/16/2022Syros Pharmaceuticals, Inc.SYRSGrantRestricted Stock Units8k$0.00$0 09/16/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionCommon Stock2k$76.00$152k 08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)17k$70.60$1.2M 08/17/2022
08/17/2022Turning Point Therapeutics, Inc.TPTXDispositionStock Option (right to buy)209$65.64$13.7k 08/17/2022
06/01/2022Syros Pharmaceuticals, Inc.SYRSGrantStock Option (right to buy)17.5k$0.78$13.6k 06/01/2022
05/24/2022BIOMARIN PHARMACEUTICAL INCBMRNGrantCommon Stock5k$0.00$0 05/24/2022
01/03/2022BIOMARIN PHARMACEUTICAL INCBMRNGrantCommon Stock2.3k$0.00$0 01/03/2022
06/21/2021Turning Point Therapeutics, Inc.TPTXPurchaseCommon Stock2k$81.34$162.7k 06/21/2021
06/08/2021Syros Pharmaceuticals, Inc.SYRSGrantStock Option (right to buy)17.5k$6.30$110.2k 06/08/2021
06/02/2021Turning Point Therapeutics, Inc.TPTXGrantStock Option (right to buy)209$65.64$13.7k 06/02/2021
05/24/2021Turning Point Therapeutics, Inc.TPTXGrantStock Option (right to buy)17k$70.60$1.2M 05/24/2021
06/11/2020Syros Pharmaceuticals, Inc.SYRSGrantStock Option (right to buy)17.5k$9.17$160.5k 06/11/2020
05/13/2020Syros Pharmaceuticals, Inc.SYRSPurchaseCommon Stock10k$8.86$88.6k 05/13/2020
12/19/2019Syros Pharmaceuticals, Inc.SYRSGrantStock Option (right to buy)35k$6.22$217.7k 12/19/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)33.9k$124.06$4.2M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)33.9k$135.41$4.6M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)33.9k$100.97$3.4M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)29.7k$113.18$3.4M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)33.9k$103.26$3.5M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)59.2k$83.13$4.9M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)59.2k$88.91$5.3M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionStock Option (right to buy)59.2k$71.43$4.2M 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionRestricted Stock Unit17.1k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDisposition 30.1k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionRestricted stock Unit18.8k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionRestricted Stock Unit115.8k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGGrantCommon Stock25.7k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGGrantCommon Stock45.1k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGGrantCommon Stock74.4k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionCommon Stock366.5k$0.00$0 11/20/2019
11/20/2019CELGENE CORP /DE/CELGDispositionCommon Stock6.3k$0.00$0401(k) Plan11/20/2019
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy